Evaluating the value of 18F-PSMA-1007 PET/CT in the detection and identification of prostate cancer using histopathology as the standard
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluating the value of 18F-PSMA-1007 PET/CT in the detection and identification of prostate cancer using histopathology as the standard
Authors
Keywords
-
Journal
CANCER IMAGING
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1186/s40644-023-00627-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lymph node staging with fluorine-18 prostate specific membrane antigen 1007-positron emission tomography/computed tomography in newly diagnosed intermediate- to high-risk prostate cancer using histopathological evaluation of extended pelvic node dissection as reference
- (2022) Rick Hermsen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
- (2022) Wojciech Cytawa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
- (2022) Kunal Ramesh Chandekar et al. CLINICAL NUCLEAR MEDICINE
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor detection of 18F-PSMA-1007 in the prostate gland in patients with prostate cancer using prostatectomy specimens as reference method
- (2021) Elin Tragardh et al. JOURNAL OF NUCLEAR MEDICINE
- Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI with histopathology gold-standard in the detection, intra-prostatic localization and local extension of primary prostate cancer: results from a prospective single-center imaging trial
- (2021) Ida Sonni et al. JOURNAL OF NUCLEAR MEDICINE
- Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
- (2021) Venkata Avinash Chikatamarla et al. EJNMMI Research
- 18F-PSMA-1007 PET/CT Performance on Risk Stratification Discrimination and Distant Metastases Prediction in Newly Diagnosed Prostate Cancer
- (2021) Zhuonan Wang et al. Frontiers in Oncology
- Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
- (2020) Stefano Fanti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology
- (2020) Bastiaan M. Privé et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Matched-pair comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy
- (2019) Isabel Rauscher et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of three interpretation criteria of 68Ga-PSMA11 PET based on inter- and intra-reader agreement
- (2019) Akira Toriihara et al. JOURNAL OF NUCLEAR MEDICINE
- Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
- (2019) Daniela A. Ferraro et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
- (2017) Sara Sheikhbahaei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer
- (2017) Nicholas M. Donin et al. JOURNAL OF NUCLEAR MEDICINE
- Intraindividual Comparison of18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study
- (2017) Claudia Kesch et al. JOURNAL OF NUCLEAR MEDICINE
- Immunohistochemical Validation of PSMA Expression Measured by68Ga-PSMA PET/CT in Primary Prostate Cancer
- (2017) Nadine Woythal et al. JOURNAL OF NUCLEAR MEDICINE
- F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
- (2016) Frederik L. Giesel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer
- (2016) H. Rhee et al. JOURNAL OF UROLOGY
- Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
- (2009) U. Elsasser-Beile et al. CURRENT DRUG TARGETS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation